Biodyne Co., Ltd.

KOSDAQ:A314930 Stock Report

Market Cap: ₩561.6b

Biodyne Past Earnings Performance

Past criteria checks 0/6

Biodyne has been growing earnings at an average annual rate of 53%, while the Medical Equipment industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 18% per year.

Key information

53.0%

Earnings growth rate

62.5%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate18.0%
Return on equity-2.1%
Net Margin-21.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Should You Investigate Biodyne Co., Ltd. (KOSDAQ:314930) At ₩19,100?

Oct 23
Should You Investigate Biodyne Co., Ltd. (KOSDAQ:314930) At ₩19,100?

Is There Now An Opportunity In Biodyne Co., Ltd. (KOSDAQ:314930)?

Jul 16
Is There Now An Opportunity In Biodyne Co., Ltd. (KOSDAQ:314930)?

Companies Like Biodyne (KOSDAQ:314930) Are In A Position To Invest In Growth

Jun 05
Companies Like Biodyne (KOSDAQ:314930) Are In A Position To Invest In Growth

Revenue & Expenses Breakdown

How Biodyne makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A314930 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244,196-8932,164291
31 Mar 244,076-1,3322,026348
31 Dec 234,089-9921,832383
30 Sep 2311,7874,8691,752431
30 Jun 2312,0645,4771,743428
31 Mar 2311,9265,8321,675422
31 Dec 2212,2105,6111,819412
30 Sep 225,204-2001,930353
30 Jun 224,567-9951,929359
31 Mar 224,506-1,1601,924383
31 Dec 213,763-10,8572,159391
30 Sep 213,301-12,7711,989472
30 Jun 213,375-13,4391,849463
31 Mar 213,380-13,7721,847451
31 Dec 203,671-4,4541,589445
30 Sep 204,273-4,3022,378667
31 Dec 194,089-2,0262,082534
31 Dec 183,771-1,3801,180181
31 Dec 174,6975131,346158
31 Dec 153,609-1571,363189
31 Dec 143,024-971,034305

Quality Earnings: A314930 is currently unprofitable.

Growing Profit Margin: A314930 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A314930 is unprofitable, but has reduced losses over the past 5 years at a rate of 53% per year.

Accelerating Growth: Unable to compare A314930's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A314930 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.6%).


Return on Equity

High ROE: A314930 has a negative Return on Equity (-2.07%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies